Indigenous Bloom Hemp Corporation (CE) (VRTHF) Cotización

VRTHD changed back to VRTHF. Perhaps the reverse split was either cancelled or improperly noted by FINRA.

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Veritas Pharma Inc. changed to Indigenous Bloom Hemp Corp. and a one for 2 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

VRTHF one for 2 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

https://seekingalpha.com/pr/17880373-veritas-signs-letter-of-intent-to-acquire-indigenous-bloom-hemp-corporation

I've ignored this company for over a year, R/S panned out to nothing...VRTHF has its own website...GLTU...

Can anybody please tell us what properties VRTHF has just now? Maybe this will help to realize what opportunity are here.

Thanks!!!

and as I scroll through the posts on the VRTHF board I can see R/S and links to prs regarding the R/S...shouldn't be any questions, just click the pr and read...

Wasn’t this just five cents a few days ago, and now it’s $.54

what uptick for VRTHF???

I’m just watching this but can’t find any news on this one. Know why the uptick?

VRTHF r/s went through a couple weeks ago...

So I’m guessing because of today’s uptick, the reverse split finally went through

https://globenewswire.com/news-release/2019/02/11/1716845/0/en/Veritas-leads-Puerto-Rico-partnership-with-approval-of-new-Investigation-License.html

https://globenewswire.com/news-release/2019/02/11/1720452/0/en/Veritas-Pharma-Announces-the-Resignation-of-CEO-Dr-Lui-Franciosi.html

So CTL-X trials have finally started, and Lui resigns...

What's going on here?

VRTHF one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

a pr is a Press Release...VRTHF popped on this pr...https://globenewswire.com/news-release/2019/01/15/1691742/0/en/Veritas-Pharma-Signs-MOU-with-Santa-Marta-Gold-Holdings-for-a-Medical-Cannabis-Research-Collaboration.html

Veritas Pharma Signs MOU with Santa Marta Gold Holdings for a Medical Cannabis Research Collaboration

January 15, 2019 09:00 ET | Source: Veritas Pharma Inc.

VANCOUVER, British Columbia, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with Santa Marta Gold Holdings Ltd. (“Santa Marta”) where both companies will share the intellectual property (“IP”) jointly developed as part of a proposed agreement that outlines a medical cannabis research collaboration.

Under the terms of the MOU, both companies wish to collaborate in a structured, scientific manner with respect to formally identifying and cooperating on the advancement of medical cannabis strains or cultivars as well as to jointly develop, commercialize and patent protect medicinal products to treat specific diseases and chronic conditions.

Veritas’ CEO, Dr. Lui Franciosi stated, “Santa Marta will enable the scientists at Cannevert Therapeutics Ltd. (“CTL”) to obtain a variety of cannabis strains in the near future with the aim of discovering and developing proprietary products that have consistent and optimal clinical effects. This will be another example of a great partnership for the science and business of medical cannabis”.

Santa Marta’s director, Rafael Cotes Pardo, stated, “After meeting with Dr. Franciosi, and Prof. Michael Walker this week in Vancouver, and touring the Cannevert lab at UBC, I am extremely excited to enter into this agreement with the Veritas and Cannevert teams to explore the medical benefits of cannabis in a scientific manner. Our primary goal is to improve people’s quality of life through the medical cannabis, and we feel that this is the perfect team to align ourselves with to reach that goal”.

The definitive agreement is expected to be finalized by Q2 of this year.

About Santa Marta Gold Holding Ltd.
Santa Marta Gold Holdings Ltd. is a Canadian company with a wholly owned subsidiary VDL Colombia SAS, a Colombian company, which has a late stage application with the Colombian government to a be licensed producer of both cannabis and hemp. It has access to 35 hectares of farm land just outside of Santa Marta, Colombia, including a genetic library of nearly 1000 different cannabis cultivars registered with the Instituto Colombiano Agropecuario. SMGH also has plans to do outdoor industrial hemp production as well as indoor controlled environments for CBD and THC dominant strains to manufacture high grade cannabis oils for the international medical market. Their facilities are designed to European Union Good Manufacturing Practices (GMP) standards.

About Veritas Pharma Inc.
Veritas Pharma Inc. is an emerging pharmaceutical and IP development company, who, through its 100% owned subsidiary Cannevert Therapeutics Ltd. (“CTL“), is advancing the science behind medical cannabis. It is the Company’s aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims. CTL’s unique value proposition uses a low-cost research and development model to help drive shareholder value, and speed-to-market. Veritas’ investment in CTL is led by a strong management team, bringing together veteran academic pharmacologists, anesthetists & chemists. The company’s commercial mission is to patent protect IP (cultivars & strains) and sell or license to cancer clinics, insurance industry and pharma, targeting multi-billion-dollar markets according to Deloitte’s Insights and Opportunities.

Veritas Pharma Inc. is a publicly traded company in Canada, on the Canadian Stock Exchange under the ticker VRT; in the United States, on the OTC under the ticker VRTHF; and in Germany, on the Frankfurt exchange under the ticker 2VP.

For more information, please visit our website: www.veritaspharmainc.com

On behalf of the Board of Directors

"Dr. Lui Franciosi"
Dr. Lui Franciosi
President and Chief Executive Officer

Further information about the Company is available on our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com and on the CSE website at www.thecse.com.

Investor and Public Relations Contact
Veritas Pharma Inc.
Sam Eskandari
Telephone: +1.416.918.6785
Email: ir@veritaspharmainc.com
Website: www.veritaspharmainc.com

The CSE has not reviewed, nor approved or disapproved the content of this press release.

What is a pr? I don't see the embedded charts today?

Looks like VRTHF had a pr yesterday, I didn't notice until today, its embedded link must still work with stockcharts...

Dealer noticed that your VRTHF charts are still working as embedded charts in your iBox. I noticed that there is no moderator for the board. Does anyone know how that are getting the chart to still embed? TIA.

VRTHF chart show some stability and trading sideways for now, hopefully there will be another pop soon b4 R/S, when will R/S happen anyway??? It won't be that big imo first of all, but could still be damaging to pps afterward...

I was in mrphf for 6 months hit that big pop and sold... They are struggling right now I feel bad for anyone who got in above. 20

hopefully there will be a little rebound b4 R/S happens for VRTHF...got in @ .175 last month...

This easy one of my fav companies and i sold it this reverse split will prob not help any

why are you rubbing my nose in it??? that's not nice...

How did that work out?

it doesn't... unless VRTHF bounces back, I will sell Thrusday and move on...

Dr. Lui Franciosi, CEO of Veritas states that, “The closing of this financing and the share consolidation provide Veritas with the opportunity to not only secure clients for its new cannabis testing services, it also will provide the Company with the necessary positive ongoing cash flow for the continued research, development and commercialization of cannabis strains specific to pain management and treatment of specific diseases.”

Please explain to me how a reverse split contributes to any of this in a positive way.

Yep!

Up a mile and no posts here. lol

Are u voting no on the RS?

SO will BOD still do the VRTHF R/S 10:1???

NEWS OUT!! https://www.ftmig.com/company-news-releases/veritas-confirms-readiness-for-human-trials-of-ctl-x-for-pain-projected-to-start-early-next-month/

VRTHF going through 10:1 R/S...

YES!!! VRTHF WORDED the r/s differently...The Company would also like to announce, subject to shareholder and regulatory approval, that it will be consolidating its shares on a 10 to 1 basis.

http://veritaspharmainc.com/2018/11/06/veritas-announces-first-closing-financing/

GOOGLE IT!!! https://www.google.com/search?q=vrthf+reverse+split&ie=utf-8&oe=utf-8&client=firefox-b-1

Doesn't look like VRTHF is going through reverse split...why???

Is this company doing a reverse stock split..

http://veritaspharmainc.com/

What does this company do, I like the charts, but have no idea the business model. Is this a cbd play, do they have revenues, please give me some insights.

hopefully VRTHF is rebounding...I'd hate to buy more shares if the decline continues past support...

If we get heavy volume we're flying!

$VRTHF NEWS

Veritas signs MOU with IMC of Puerto Rico https://seekingalpha.com/news/3395447?source=ansh $VRTHF

MOU w Agrima

https://mailchi.mp/veritaspharmainc/veritas-pharma-inc-updates-1811825?e=4ad7479db5

I don't mind a pm regarding VRTHF...I can't respond through pm until Friday afternoons...

You might as well be a mm. Slap that ask!

VRTHF https://www.marketscreener.com/VERITAS-PHARMA-INC-33624669/news/Veritas-Pharma-Announces-2-5-Million-Private-Placement-Offering-27292359/

Did anyone read about a private placement??

not true, why pay 10% 20 $ premium for the same thing as long as they get filled good for them...the pps will rise eventually...VRTHF

I wish everyone would buy at the ASK so we can get moving up. They keep their own stock down when they're stingy.

Volume picking up on cdn exchange and otc exchange

Sleeping GIANT$

Very interesting stock